Company · CIK 0000872589 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
REGENERON PHARMACEUTICALS, INC. · REGN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2017 MForm 4 → | Jun 14, 4:36 pm EDT | Michael S BrownDirector | 2,000 | $177.82 | $355,640 | 2,000 | — | plan? |
| Jun 9, 2017 SForm 4 → | Jun 13, 5:06 pm EDT | Joseph L GoldsteinDirector | 1,000 | $482.55 | $482,550 | 13,000 | −7.14% | plan? |
| Jun 9, 2017 MForm 4 → | Jun 13, 5:06 pm EDT | Joseph L GoldsteinDirector | 1,000 | $273.67 | $273,670 | 14,000 | — | plan? |
| Jun 2, 2017 PForm 4 → | Jun 6, 5:00 pm EDT | Sanofi10% Owner | 136,050 | $478.17 | $65,055,558 | 23,641,744 | +0.58% | plan? |
| Jun 2, 2017 SForm 4 → | Jun 5, 4:52 pm EDT | Neil StahlEVP Research and Development | 2,812 | $479.49 | $1,348,314 | 23,950 | −10.5% | plan? |
| Jun 1, 2017 FMForm 4 → | Jun 5, 4:52 pm EDT | Neil StahlEVP Research and Development | 18,276 | $311.17 | $5,686,949 | 26,762 | — | plan? |
| May 25, 2017 SForm 4 → | May 26, 4:04 pm EDT | P Roy VagelosChairman of the Board, Director | 9,295 | $458.14 | $4,258,373 | 83,652 | −10.0% | plan? |
| May 12, 2017 SForm 4 → | May 15, 4:07 pm EDT | Michael S BrownDirector | 3,000 | $450.00 | $1,350,000 | 0 | −100% | plan? |
| May 12, 2017 MForm 4 → | May 15, 4:07 pm EDT | Michael S BrownDirector | 3,000 | $177.82 | $533,460 | 3,000 | — | plan? |
| May 5, 2017 GForm 5 → | Feb 5, 2018, 4:02 pm EST | Arthur F RyanDirector | 3,500 | — | — | 32,000 | — | plan? |
| Mar 29, 2017 SForm 4 → | Mar 30, 4:42 pm EDT | Michael S BrownDirector | 1,000 | $400.00 | $400,000 | 0 | −100% | plan? |
| Mar 29, 2017 MForm 4 → | Mar 30, 4:42 pm EDT | Michael S BrownDirector | 1,000 | $177.82 | $177,820 | 1,000 | — | plan? |
| Jan 11, 2017 PForm 4 → | Jan 13, 4:15 pm EST | Sanofi10% Owner | 87,298 | $369.71 | $32,274,872 | 23,505,694 | +0.37% | plan? |
| Jan 3, 2017 GForm 4 → | May 26, 4:04 pm EDT | P Roy VagelosChairman of the Board, Director | 1,118 | — | — | 150,707 | — | plan? late |
| Jan 3, 2017 MForm 4 → | Jan 4, 4:12 pm EST | George L SingDirector | 7,000 | $19.69 | $137,830 | 119,772 | — | plan? |
| Dec 20, 2016 GForm 5 → | Feb 10, 2017, 8:31 pm EST | George YancopoulosPresident & CSO, Director | 3,918 | — | — | 64,058 | — | plan? |
| Dec 15, 2016 FMForm 4 → | Dec 19, 4:07 pm EST | Leonard S SchleiferPresident & CEO, Director | 385,397 | $146.71 | $56,543,046 | 157,409 | — | plan? |
| Dec 12, 2016 SForm 4 → | Dec 14, 5:41 pm EST | Charles A BakerDirector | 3,000 | $392.02 | $1,176,048 | 9,000 | −25.0% | plan? |
| Dec 12, 2016 MForm 4 → | Dec 14, 5:41 pm EST | Charles A BakerDirector | 3,000 | $18.61 | $55,830 | 12,000 | — | plan? |
| Nov 22, 2016 GForm 4 → | Dec 20, 4:29 pm EST | P Roy VagelosChairman of the Board, Director | 59,788 | — | — | 414,156 | — | plan? late |
| Nov 15, 2016 GForm 4 → | Nov 16, 4:21 pm EST | Arthur F RyanDirector | 1,000 | — | — | 35,500 | — | plan? |
| Nov 15, 2016 SForm 4 → | Nov 16, 4:21 pm EST | Arthur F RyanDirector | 2,000 | $429.34 | $858,680 | 36,500 | −5.19% | plan? |
| Nov 14, 2016 SForm 4 → | Nov 15, 4:08 pm EST | Joseph L GoldsteinDirector | 2,125 | $450.00 | $956,250 | 13,000 | −14.0% | plan? |
| Nov 14, 2016 MForm 4 → | Nov 15, 4:08 pm EST | Joseph L GoldsteinDirector | 2,125 | $273.67 | $581,549 | 15,125 | — | plan? |
| Sep 1, 2016 FForm 4 → | Sep 2, 4:02 pm EDT | Joseph J LarosaSVP General Counsel and Secret | 4,943 | $392.63 | $1,940,770 | 11,813 | — | plan? |
| Jul 29, 2016 SForm 4 → | Aug 1, 4:04 pm EDT | Joseph L GoldsteinDirector | 2,125 | $425.00 | $903,125 | 13,000 | −14.0% | plan? |
| Jul 29, 2016 MForm 4 → | Aug 1, 4:04 pm EDT | Joseph L GoldsteinDirector | 2,125 | $273.67 | $581,549 | 15,125 | — | plan? |
| Jul 21, 2016 FGMForm 4 → | Dec 19, 4:09 pm EST | George YancopoulosPresident Regeneron Laboratori, Director | 1,300,731 | $146.71 | $44,121,274 | 67,976 | — | plan? late |
| Jul 1, 2016 FGMForm 4 → | Nov 9, 4:10 pm EST | P Roy VagelosChairman of the Board, Director | 119,816 | $138.33 | $16,416,843 | 151,825 | — | plan? late |
| Jun 14, 2016 PForm 4 → | Jun 16, 5:47 pm EDT | Sanofi10% Owner | 64,731 | $363.86 | $23,552,859 | 23,418,396 | +0.28% | plan? |
| May 24, 2016 SForm 4 → | May 25, 4:02 pm EDT | Arthur F RyanDirector | 1,000 | $396.64 | $396,640 | 39,500 | −2.47% | plan? |
| May 18, 2016 SForm 4 → | May 19, 4:26 pm EDT | Daniel P Van PlewEVP & General Mgr Industrial O | 4,413 | $385.77 | $1,702,403 | 1,921 | −69.7% | plan? |
| May 17, 2016 FMForm 4 → | May 19, 4:26 pm EDT | Daniel P Van PlewEVP & General Mgr Industrial O | 14,507 | $155.01 | $2,248,702 | 6,334 | — | plan? |
| May 16, 2016 GForm 4 → | Dec 19, 4:15 pm EST | Peter PowchikSVP Clinical Development & Reg | 9,836 | — | — | 2,459 | — | plan? late |
| Apr 6, 2016 MForm 4 → | Apr 7, 4:19 pm EDT | Joseph L GoldsteinDirector | 1,000 | $177.82 | $177,820 | 14,000 | — | plan? |
| Apr 6, 2016 SForm 4 → | Apr 7, 4:19 pm EDT | Joseph L GoldsteinDirector | 2,000 | $425.00 | $850,000 | 13,000 | −13.3% | plan? |
| Apr 1, 2016 SForm 4 → | Apr 4, 4:16 pm EDT | Joseph L GoldsteinDirector | 2,000 | $400.00 | $800,000 | 14,000 | −12.5% | plan? |
| Apr 1, 2016 MForm 4 → | Apr 4, 4:16 pm EDT | Joseph L GoldsteinDirector | 2,000 | $177.82 | $355,640 | 16,000 | — | plan? |
| Mar 21, 2016 SForm 4 → | Mar 21, 4:27 pm EDT | Joseph L GoldsteinDirector | 2,000 | $375.00 | $750,000 | 14,000 | −12.5% | plan? |
| Mar 21, 2016 MForm 4 → | Mar 21, 4:27 pm EDT | Joseph L GoldsteinDirector | 2,000 | $177.82 | $355,640 | 16,000 | — | plan? |
| Feb 26, 2016 GForm 4 → | May 25, 4:02 pm EDT | Arthur F RyanDirector | 2,000 | — | — | 38,500 | — | plan? late |
| Feb 19, 2016 GForm 4 → | Dec 20, 4:28 pm EST | Neil StahlEVP Research and Development | 9,376 | — | — | 23,950 | — | plan? late |
| Feb 16, 2016 PForm 4 → | Feb 18, 5:45 pm EST | Sanofi10% Owner | 161,157 | $392.46 | $63,247,910 | 23,353,665 | +0.69% | plan? |
| Jan 12, 2016 PForm 4 → | Jan 14, 5:46 pm EST | Sanofi10% Owner | 83,938 | $465.04 | $39,034,660 | 23,192,508 | +0.36% | plan? |
| Jan 4, 2016 FGMForm 4 → | May 13, 4:40 pm EDT | P Roy VagelosChairman of the Board, Director | 356,388 | $142.58 | $50,676,556 | 152,964 | — | plan? late |
| Dec 29, 2015 SForm 4 → | Dec 29, 7:44 pm EST | Douglas S McCorkleVP Controller and Asst Treasur | 3,954 | $552.08 | $2,182,924 | 6,866 | −36.5% | plan? |
| Dec 29, 2015 MForm 4 → | Dec 29, 7:44 pm EST | Douglas S McCorkleVP Controller and Asst Treasur | 3,954 | $52.03 | $205,727 | 10,820 | — | plan? |
| Dec 17, 2015 MForm 4 → | Dec 18, 4:28 pm EST | Michael S AbermanSVP Strategy Investor Relation | 4,000 | $24.00 | $96,000 | 16,498 | — | plan? |
| Dec 16, 2015 MForm 4 → | Dec 18, 4:28 pm EST | Douglas S McCorkleVP Controller and Asst Treasur | 1,921 | $52.03 | $99,950 | 6,866 | — | plan? |
| Dec 16, 2015 MForm 4 → | Dec 18, 4:27 pm EST | Peter PowchikSVP Clinical Development & Reg | 1,921 | $52.03 | $99,950 | 17,742 | — | plan? |
| Dec 16, 2015 MForm 4 → | Dec 18, 4:27 pm EST | Neil StahlEVP Research and Development | 1,921 | $52.03 | $99,950 | 27,594 | — | plan? |
| Dec 16, 2015 MForm 4 → | Dec 18, 4:27 pm EST | Daniel P Van PlewSVP & General Mgr Industrial O | 1,921 | $52.03 | $99,950 | 1,921 | — | plan? |
| Dec 16, 2015 MForm 4 → | Dec 18, 4:26 pm EST | George YancopoulosPresident Regeneron Laboratori, Director | 1,921 | $52.03 | $99,950 | 501,921 | — | plan? |
| Dec 10, 2015 SForm 4 → | Dec 11, 4:14 pm EST | Michael S BrownDirector | 3,000 | $546.45 | $1,639,365 | 0 | −100% | plan? |
| Dec 10, 2015 MForm 4 → | Dec 11, 4:14 pm EST | Michael S BrownDirector | 3,000 | $177.82 | $533,460 | 3,000 | — | plan? |
| Dec 2, 2015 SForm 4 → | Dec 4, 4:13 pm EST | George YancopoulosPresident Regeneron Laboratori, Director | 43,348 | $549.03 | $23,799,539 | 500,000 | −7.98% | plan? |
| Nov 18, 2015 SForm 4 → | Nov 20, 4:04 pm EST | George L SingDirector | 3,500 | $580.00 | $2,030,000 | 4,500 | −43.8% | plan? |
| Nov 18, 2015 MForm 4 → | Nov 20, 4:04 pm EST | George L SingDirector | 3,000 | $19.69 | $59,070 | 115,772 | — | plan? |
| Nov 18, 2015 SForm 4 → | Nov 19, 4:20 pm EST | P Roy VagelosChairman of the Board, Director | 17,240 | $587.90 | $10,135,312 | 334,611 | −4.90% | plan? |
| Nov 16, 2015 GForm 4 → | Dec 4, 4:13 pm EST | George YancopoulosPresident Regeneron Laboratori, Director | 1,612 | — | — | 567,976 | — | plan? late |
| Nov 10, 2015 SForm 4 → | Nov 10, 4:06 pm EST | Daniel P Van PlewSVP & General Mgr Industrial O | 5,123 | $554.85 | $2,842,520 | 0 | −100% | plan? |
| Nov 6, 2015 FMForm 4 → | Nov 10, 4:06 pm EST | Daniel P Van PlewSVP & General Mgr Industrial O | 17,249 | $216.52 | $3,734,815 | 5,123 | — | plan? |
| Nov 6, 2015 SForm 4 → | Nov 9, 5:10 pm EST | Neil StahlEVP Research and Development | 42,101 | $561.45 | $23,637,627 | 22,029 | −65.6% | plan? |
| Nov 5, 2015 GForm 4 → | Jan 6, 2016, 4:02 pm EST | Michael S BrownDirector | 1,000 | — | — | 17,349 | — | plan? late |
| Nov 5, 2015 GForm 4 → | Jan 6, 2016, 4:02 pm EST | Arthur F RyanDirector | 6,000 | — | — | 41,500 | — | plan? late |
| Nov 2, 2015 GForm 4 → | Dec 14, 2018, 4:21 pm EST | George YancopoulosPresident and CSO, Director | 3,268,478 | — | — | 400,000 | — | plan? late |
| Nov 2, 2015 SForm 4 → | Nov 4, 4:05 pm EST | P Roy VagelosChairman of the Board, Director | 17,242 | $580.19 | $10,003,663 | 351,851 | −4.67% | plan? |
| Nov 2, 2015 SForm 4 → | Nov 3, 4:20 pm EST | George YancopoulosPresident Regeneron Laboratori, Director | 43,348 | $571.61 | $24,778,125 | 543,348 | −7.39% | plan? |
| Oct 30, 2015 FMForm 4 → | Nov 3, 4:20 pm EST | George YancopoulosPresident Regeneron Laboratori, Director | 278,940 | $200.29 | $55,867,889 | 586,696 | — | plan? |
| Oct 6, 2015 PForm 4 → | Oct 8, 5:50 pm EDT | Sanofi10% Owner | 11,040 | $472.33 | $5,214,519 | 23,108,570 | +0.05% | plan? |
| Oct 6, 2015 PForm 4 → | Oct 8, 5:45 pm EDT | Sanofi10% Owner | 80,538 | $459.71 | $37,024,197 | 23,097,530 | +0.35% | plan? |
| Oct 1, 2015 GForm 4 → | Nov 19, 4:20 pm EST | P Roy VagelosChairman of the Board, Director | 2,186 | — | — | 153,935 | — | plan? late |
| Sep 23, 2015 PForm 4 → | Sep 25, 5:45 pm EDT | Sanofi10% Owner | 147,209 | $534.67 | $78,708,570 | 23,016,992 | +0.64% | plan? |
| Sep 21, 2015 SForm 4 → | Sep 22, 2:39 pm EDT | Michael S BrownDirector | 3,000 | $551.55 | $1,654,650 | 0 | −100% | plan? |
| Sep 21, 2015 MForm 4 → | Sep 22, 2:39 pm EDT | Michael S BrownDirector | 3,000 | $57.11 | $171,330 | 3,000 | — | plan? |
| Sep 17, 2015 SForm 4 → | Sep 18, 4:06 pm EDT | Charles A BakerDirector | 5,000 | $550.00 | $2,750,000 | 9,000 | −35.7% | plan? |
| Sep 17, 2015 MForm 4 → | Sep 18, 4:06 pm EDT | Charles A BakerDirector | 5,000 | $18.61 | $93,050 | 14,000 | — | plan? |
| Sep 2, 2015 FMForm 4 → | Sep 3, 4:59 pm EDT | Leonard S SchleiferPresident & CEO, Director | 13,733 | $451.82 | $6,204,788 | 42,806 | — | plan? |
| Sep 1, 2015 MForm 4 → | Sep 2, 4:04 pm EDT | Joseph J LarosaSVP General Counsel and Secret | 1,689 | $59.20 | $99,989 | 16,756 | — | plan? |
| Aug 14, 2015 SForm 4 → | Aug 17, 4:01 pm EDT | Peter PowchikSVP Clinical Development & Reg | 23,485 | $573.38 | $13,465,866 | 15,821 | −59.7% | plan? |
| Aug 13, 2015 FMForm 4 → | Aug 17, 4:01 pm EDT | Peter PowchikSVP Clinical Development & Reg | 97,237 | $292.54 | $28,446,181 | 39,306 | — | plan? |
| Aug 12, 2015 SForm 4 → | Aug 12, 4:45 pm EDT | Christine A PoonDirector | 112 | $564.16 | $63,186 | 790 | −12.4% | plan? |
| Aug 11, 2015 FMForm 4 → | Aug 12, 4:45 pm EDT | Christine A PoonDirector | 693 | $370.50 | $256,754 | 902 | — | plan? |
| Aug 6, 2015 SForm 4 → | Aug 7, 6:15 pm EDT | Alfred G GilmanDirector | 5,000 | $587.12 | $2,935,601 | 8,912 | −35.9% | plan? |
| Aug 6, 2015 MForm 4 → | Aug 7, 6:15 pm EDT | Alfred G GilmanDirector | 5,000 | $57.11 | $285,550 | 13,912 | — | plan? |
| Aug 6, 2015 SForm 4 → | Aug 7, 6:14 pm EDT | Robert J TerifaySVP Commercial | 13,423 | $588.97 | $7,905,781 | 23,293 | −36.6% | plan? |
| Aug 6, 2015 SForm 4 → | Aug 7, 6:13 pm EDT | Daniel P Van PlewSVP & General Mgr Industrial O | 4,028 | $584.36 | $2,353,807 | 0 | −100% | plan? |
| Aug 5, 2015 FMForm 4 → | Aug 7, 6:14 pm EDT | Robert J TerifaySVP Commercial | 48,313 | $213.27 | $10,303,639 | 36,716 | — | plan? |
| Aug 5, 2015 FMForm 4 → | Aug 7, 6:13 pm EDT | Daniel P Van PlewSVP & General Mgr Industrial O | 13,372 | $222.72 | $2,978,196 | 4,028 | — | plan? |
| Aug 5, 2015 SForm 4 → | Aug 6, 9:00 pm EDT | Robert E LandrySVP Finance & CFO | 4,000 | $592.84 | $2,371,350 | 7,099 | −36.0% | plan? |
| Aug 5, 2015 MForm 4 → | Aug 6, 9:00 pm EDT | Robert E LandrySVP Finance & CFO | 4,000 | $272.70 | $1,090,800 | 11,099 | — | plan? |
| Aug 5, 2015 SForm 4 → | Aug 5, 8:58 pm EDT | Douglas S McCorkleVP Controller and Asst Treasur | 5,000 | $585.53 | $2,927,648 | 4,945 | −50.3% | plan? |
| Aug 5, 2015 MForm 4 → | Aug 5, 8:58 pm EDT | Douglas S McCorkleVP Controller and Asst Treasur | 5,000 | $270.43 | $1,352,150 | 9,745 | — | plan? |
| Aug 5, 2015 SForm 4 → | Aug 5, 8:55 pm EDT | Marc Tessier-LavigneDirector | 5,000 | $590.26 | $2,951,275 | 1,187 | −80.8% | plan? |
| Aug 5, 2015 MForm 4 → | Aug 5, 8:55 pm EDT | Marc Tessier-LavigneDirector | 5,000 | $57.11 | $285,550 | 6,187 | — | plan? |
| Aug 4, 2015 SForm 4 → | Aug 5, 10:03 am EDT | Joseph L GoldsteinDirector | 2,000 | $586.00 | $1,172,000 | 14,000 | −12.5% | plan? |
| Jul 31, 2015 CForm 4 → | Aug 3, 7:23 pm EDT | Alfred G GilmanDirector | 8,912 | — | — | 8,912 | — | plan? |
| Jul 27, 2015 PForm 4 → | Jul 29, 5:46 pm EDT | Sanofi10% Owner | 10,639 | $537.48 | $5,718,272 | 22,869,783 | +0.05% | plan? |
| Jul 15, 2015 SForm 4 → | Jul 15, 4:09 pm EDT | Joseph L GoldsteinDirector | 2,000 | $550.00 | $1,100,000 | 16,000 | −11.1% | plan? |
| Jun 22, 2015 SForm 4 → | Jun 22, 5:02 pm EDT | Joseph L GoldsteinDirector | 2,000 | $526.85 | $1,053,700 | 18,000 | −10.0% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2016 MForm 4 → | Dec 14, 5:41 pm EST | Charles A BakerDirector | 3,000 | — | — | 2,000 | — | |
| Nov 14, 2016 MForm 4 → | Nov 15, 4:08 pm EST | Joseph L GoldsteinDirector | 2,125 | — | — | 8,500 | — | |
| Nov 7, 2016 MForm 4 → | Nov 9, 4:10 pm EST | P Roy VagelosChairman of the Board, Director | 76,895 | — | — | 0 | — | |
| Sep 9, 2016 AForm 4 → | Sep 12, 4:25 pm EDT | Huda Y ZoghbiDirector | 15,353 | — | — | 15,353 | — | |
| Sep 9, 2016 AForm 4 → | Sep 12, 4:24 pm EDT | Bonnie L BasslerDirector | 15,353 | — | — | 15,353 | — | |
| Jul 29, 2016 MForm 4 → | Aug 1, 4:04 pm EDT | Joseph L GoldsteinDirector | 2,125 | — | — | 10,625 | — | |
| May 17, 2016 MForm 4 → | May 19, 4:26 pm EDT | Daniel P Van PlewEVP & General Mgr Industrial O | 9,460 | — | — | 32,735 | — | |
| May 12, 2016 MForm 4 → | May 13, 4:40 pm EDT | P Roy VagelosChairman of the Board, Director | 230,684 | — | — | 76,895 | — | |
| Apr 6, 2016 MForm 4 → | Apr 7, 4:19 pm EDT | Joseph L GoldsteinDirector | 1,000 | — | — | 0 | — | |
| Apr 1, 2016 MForm 4 → | Apr 4, 4:16 pm EDT | Joseph L GoldsteinDirector | 2,000 | — | — | 1,000 | — | |
| Mar 21, 2016 MForm 4 → | Mar 21, 4:27 pm EDT | Joseph L GoldsteinDirector | 2,000 | — | — | 3,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:02 pm EST | Michael S BrownDirector | 9,212 | — | — | 9,212 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:02 pm EST | Joseph L GoldsteinDirector | 9,212 | — | — | 9,212 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:02 pm EST | Arthur F RyanDirector | 9,212 | — | — | 9,212 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:02 pm EST | George L SingDirector | 9,212 | — | — | 9,212 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:01 pm EST | Marc Tessier-LavigneDirector | 9,212 | — | — | 9,212 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:01 pm EST | Charles A BakerDirector | 9,212 | — | — | 9,212 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:01 pm EST | Christine A PoonDirector | 9,212 | — | — | 9,212 | — | |
| Dec 29, 2015 MForm 4 → | Dec 29, 7:44 pm EST | Douglas S McCorkleVP Controller and Asst Treasur | 3,954 | — | — | 0 | — | |
| Dec 16, 2015 AMForm 4 → | Dec 18, 4:28 pm EST | Michael S AbermanSVP Strategy Investor Relation | 29,500 | — | — | 25,500 | — | |
| Dec 16, 2015 AForm 4 → | Dec 18, 4:28 pm EST | Robert E LandrySVP Finance & CFO | 28,900 | — | — | 28,900 | — | |
| Dec 16, 2015 AForm 4 → | Dec 18, 4:28 pm EST | Joseph J LarosaSVP General Counsel and Secret | 28,900 | — | — | 28,900 | — | |
| Dec 16, 2015 AMForm 4 → | Dec 18, 4:28 pm EST | Douglas S McCorkleVP Controller and Asst Treasur | 5,721 | — | — | 3,800 | — | |
| Dec 16, 2015 AMForm 4 → | Dec 18, 4:27 pm EST | Peter PowchikSVP Clinical Development & Reg | 26,921 | — | — | 25,000 | — | |
| Dec 16, 2015 AForm 4 → | Dec 18, 4:27 pm EST | Leonard S SchleiferPresident & CEO, Director | 172,723 | — | — | 172,723 | — | |
| Dec 16, 2015 AMForm 4 → | Dec 18, 4:27 pm EST | Neil StahlEVP Research and Development | 70,559 | — | — | 68,638 | — | |
| Dec 16, 2015 AForm 4 → | Dec 18, 4:27 pm EST | Robert J TerifaySVP Commercial | 40,000 | — | — | 40,000 | — | |
| Dec 16, 2015 AMForm 4 → | Dec 18, 4:27 pm EST | Daniel P Van PlewSVP & General Mgr Industrial O | 41,921 | — | — | 40,000 | — | |
| Dec 16, 2015 AMForm 4 → | Dec 18, 4:26 pm EST | George YancopoulosPresident Regeneron Laboratori, Director | 148,736 | — | — | 146,815 | — | |
| Dec 16, 2015 AForm 4 → | Dec 18, 4:26 pm EST | P Roy VagelosChairman of the Board, Director | 92,123 | — | — | 92,123 | — | |
| Dec 10, 2015 MForm 4 → | Dec 11, 4:14 pm EST | Michael S BrownDirector | 3,000 | — | — | 12,000 | — | |
| Nov 18, 2015 MForm 4 → | Nov 20, 4:04 pm EST | George L SingDirector | 3,000 | — | — | 7,000 | — | |
| Nov 6, 2015 MForm 4 → | Nov 10, 4:06 pm EST | Daniel P Van PlewSVP & General Mgr Industrial O | 11,186 | — | — | 42,195 | — | |
| Nov 5, 2015 MForm 4 → | Nov 9, 5:10 pm EST | Neil StahlEVP Research and Development | 100,000 | — | — | 46,736 | — | |
| Oct 30, 2015 MForm 4 → | Nov 3, 4:20 pm EST | George YancopoulosPresident Regeneron Laboratori, Director | 182,818 | — | — | 0 | — | |
| Sep 21, 2015 MForm 4 → | Sep 22, 2:39 pm EDT | Michael S BrownDirector | 3,000 | — | — | 0 | — | |
| Sep 17, 2015 MForm 4 → | Sep 18, 4:06 pm EDT | Charles A BakerDirector | 5,000 | — | — | 5,000 | — | |
| Sep 2, 2015 MForm 4 → | Sep 3, 4:59 pm EDT | Leonard S SchleiferPresident & CEO, Director | 7,226 | — | — | 0 | — | |
| Sep 1, 2015 MForm 4 → | Sep 2, 4:04 pm EDT | Joseph J LarosaSVP General Counsel and Secret | 1,689 | — | — | 0 | — | |
| Aug 13, 2015 MForm 4 → | Aug 17, 4:01 pm EDT | Peter PowchikSVP Clinical Development & Reg | 60,361 | — | — | 30,000 | — | |
| Aug 11, 2015 MForm 4 → | Aug 12, 4:45 pm EDT | Christine A PoonDirector | 470 | — | — | 12,280 | — | |
| Aug 6, 2015 MForm 4 → | Aug 7, 6:15 pm EDT | Alfred G GilmanDirector | 5,000 | — | — | 0 | — | |
| Aug 5, 2015 MForm 4 → | Aug 7, 6:14 pm EDT | Robert J TerifaySVP Commercial | 32,500 | — | — | 0 | — | |
| Aug 5, 2015 MForm 4 → | Aug 7, 6:13 pm EDT | Daniel P Van PlewSVP & General Mgr Industrial O | 8,700 | — | — | 53,381 | — | |
| Aug 5, 2015 MForm 4 → | Aug 6, 9:00 pm EDT | Robert E LandrySVP Finance & CFO | 4,000 | — | — | 66,000 | — | |
| Aug 5, 2015 MForm 4 → | Aug 5, 8:58 pm EDT | Douglas S McCorkleVP Controller and Asst Treasur | 5,000 | — | — | 15,000 | — | |
| Aug 5, 2015 MForm 4 → | Aug 5, 8:55 pm EDT | Marc Tessier-LavigneDirector | 5,000 | — | — | 5,000 | — | |
| Jul 31, 2015 CForm 4 → | Aug 3, 7:23 pm EDT | Alfred G GilmanDirector | 8,912 | — | — | 0 | — | |
| May 27, 2015 MForm 4 → | May 29, 4:19 pm EDT | George L SingDirector | 5,000 | — | — | 10,000 | — | |
| May 22, 2015 MForm 4 → | May 27, 4:02 pm EDT | Robert Alexander IngramDirector | 6,667 | — | — | 13,333 | — | |
| May 22, 2015 MForm 4 → | May 26, 4:32 pm EDT | Daniel P Van PlewSVP & General Mgr Industrial O | 40,050 | — | — | 57,986 | — | |
| May 22, 2015 MForm 4 → | May 26, 4:31 pm EDT | Douglas S McCorkleVP Controller and Asst Treasur | 13,464 | — | — | 13,000 | — | |
| May 19, 2015 CForm 4 → | May 20, 4:13 pm EDT | Joseph L GoldsteinDirector | 20,000 | — | — | 0 | — | |
| May 15, 2015 MForm 4 → | May 18, 4:50 pm EDT | Michael S BrownDirector | 5,000 | — | — | 3,000 | — | |
| Apr 8, 2015 MForm 4 → | Apr 9, 4:03 pm EDT | Robert E LandrySVP Finance & CFO | 10,000 | — | — | 70,000 | — | |
| Mar 25, 2015 MForm 4 → | Mar 26, 4:21 pm EDT | Joseph J LarosaSVP General Counsel and Secret | 3,097 | — | — | 1,689 | — | |
| Mar 25, 2015 MForm 4 → | Mar 26, 4:20 pm EDT | Charles A BakerDirector | 5,000 | — | — | 10,000 | — | |
| Mar 17, 2015 MForm 4 → | Mar 19, 4:05 pm EDT | Michael S AbermanSVP Strategy Investor Relation | 11,398 | — | — | 14,168 | — | |
| Mar 16, 2015 MForm 4 → | Mar 18, 6:03 pm EDT | Robert J TerifaySVP Commercial | 24,375 | — | — | 29,236 | — | |
| Mar 16, 2015 MForm 4 → | Mar 17, 4:57 pm EDT | Joseph J LarosaSVP General Counsel and Secret | 20,281 | — | — | 54,933 | — | |
| Feb 26, 2015 MForm 4 → | Feb 27, 4:32 pm EST | Marc Tessier-LavigneDirector | 3,000 | — | — | 9,279 | — | |
| Feb 23, 2015 MForm 4 → | Feb 25, 4:02 pm EST | Michael S AbermanSVP Strategy Investor Relation | 7,500 | — | — | 7,500 | — | |
| Feb 23, 2015 MForm 4 → | Feb 25, 4:01 pm EST | Robert J TerifaySVP Commercial | 24,375 | — | — | 53,611 | — | |
| Feb 20, 2015 MForm 4 → | Feb 24, 5:08 pm EST | George L SingDirector | 15,000 | — | — | 0 | — | |
| Feb 20, 2015 MForm 4 → | Feb 24, 5:08 pm EST | Daniel P Van PlewSVP & General Mgr Industrial O | 20,000 | — | — | 17,895 | — | |
| Feb 20, 2015 MForm 4 → | Feb 23, 4:07 pm EST | Michael S BrownDirector | 1,000 | — | — | 8,000 | — | |
| Feb 20, 2015 MForm 4 → | Feb 23, 4:06 pm EST | Arthur F RyanDirector | 29,250 | — | — | 8,500 | — | |
| Feb 20, 2015 MForm 4 → | Feb 20, 4:44 pm EST | Joseph L GoldsteinDirector | 5,000 | — | — | 5,000 | — | |
| Feb 13, 2015 MForm 4 → | Feb 18, 4:40 pm EST | Michael S AbermanSVP Strategy Investor Relation | 7,500 | — | — | 21,668 | — | |
| Jan 2, 2015 AForm 4 → | Jan 5, 5:26 pm EST | Arthur F RyanDirector | 10,838 | — | — | 10,838 | — | |
| Jan 2, 2015 CForm 4 → | Jan 5, 4:56 pm EST | Leonard S SchleiferPresident & CEO, Director | 1,500 | — | — | 15,775 | — | |
| Jan 2, 2015 AForm 4 → | Jan 5, 4:31 pm EST | Marc Tessier-LavigneDirector | 10,838 | — | — | 10,838 | — | |
| Jan 2, 2015 AForm 4 → | Jan 5, 4:25 pm EST | Charles A BakerDirector | 10,838 | — | — | 10,838 | — | |
| Jan 2, 2015 AForm 4 → | Jan 5, 4:23 pm EST | Christine A PoonDirector | 10,838 | — | — | 10,838 | — | |
| Jan 2, 2015 AForm 4 → | Jan 5, 4:16 pm EST | George L SingDirector | 10,838 | — | — | 10,838 | — | |
| Jan 2, 2015 AForm 4 → | Jan 5, 4:15 pm EST | Alfred G GilmanDirector | 10,838 | — | — | 10,838 | — | |
| Jan 2, 2015 AForm 4 → | Jan 5, 4:14 pm EST | Joseph L GoldsteinDirector | 10,838 | — | — | 10,838 | — | |
| Jan 2, 2015 AForm 4 → | Jan 5, 4:13 pm EST | Michael S BrownDirector | 10,838 | — | — | 10,838 | — | |
| Jan 2, 2015 AForm 4 → | Jan 5, 4:12 pm EST | Robert Alexander IngramDirector | 10,838 | — | — | 10,838 | — | |
| Dec 31, 2014 MForm 4 → | Jan 5, 2015, 4:28 pm EST | Peter PowchikSVP Clinical Development & Reg | 25,000 | — | — | 37,079 | — |